Acquired resistance to imatinib and secondary KIT exon 13 mutation in gastrointestinal stromal tumour
François Bertucci(Institut Paoli-Calmettes), Hagay Sobol(Institut de Neurobiologie de la Méditerranée)
Cited by 22
Related Papers
Comparative genomic analysis of primary tumors and metastases in breast cancer
|Oncotarget|2016|106
MARCKS protein overexpression in inflammatory breast cancer
|Oncotarget|2016|32
Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value
|International Journal of Molecular Sciences|2017|12